OUR MISSION: TO SERVE PATIENTS AMGEN harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We discover, develop, manufacture and deliver innovative medicines to help millions of patients. Our investment in R&D has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.
R&D:INVESTING IN SCIENCE AND INNOVATION TO REACH SERIOUSLY ILL PATIENTS WORLDWIDE AMGEN focus on four therapeutic areas, oncology, inflammation, general medicine and rare disease, delivering innovative medicines to help people live longer, fuller, happier lives. We pursue new ways to do science using tools like AI, generative biology and human data to discover what is not yet known and develop new precision medicines to fight the world’s toughest diseases.
Production:MAKING MEDICINES SAFELY AND RELIABLY Many of AMGEN's medicines are made through a highly complex process involving living cells. Our commitment is to deliver for 'every patient, every time' and we have a long-running reputation for the reliability of our supply chain.
Services:THE AMGEN FOUNDATION The AMGEN Foundation is inspiring the next generation of scientists and future problem solvers, providing best-in-class science education at no cost to students through its signature programs, including LabXchange, Amgen Scholars, and the Amgen Biotech Experience. To date, the Foundation has donated more than $450 million to local, regional, and international non-profits that impact society in inspiring and innovative ways.
Sales/Distribution:2023 FINANCIAL HIGHLIGHTS Total revenue $28.2 billion Product sales $26.9 billion R&D expense $4.8 billion 2023 STAFF Approximately 27,000 worldwide